Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Debt Ratio (2016 - 2023)

Historic Debt Ratio for Amicus Therapeutics (FOLD) over the last 15 years, with Q2 2023 value amounting to 0.02.

  • Amicus Therapeutics' Debt Ratio fell 2597.98% to 0.02 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.02, marking a year-over-year decrease of 2597.98%. This contributed to the annual value of 0.03 for FY2022, which is 4163.61% up from last year.
  • As of Q2 2023, Amicus Therapeutics' Debt Ratio stood at 0.02, which was down 2597.98% from 0.02 recorded in Q1 2023.
  • Amicus Therapeutics' 5-year Debt Ratio high stood at 0.21 for Q2 2020, and its period low was 0.01 during Q4 2020.
  • For the 5-year period, Amicus Therapeutics' Debt Ratio averaged around 0.08, with its median value being 0.03 (2021).
  • In the last 5 years, Amicus Therapeutics' Debt Ratio skyrocketed by 143767.5% in 2019 and then crashed by 9420.83% in 2020.
  • Over the past 5 years, Amicus Therapeutics' Debt Ratio (Quarter) stood at 0.17 in 2019, then tumbled by 94.21% to 0.01 in 2020, then surged by 107.99% to 0.02 in 2021, then skyrocketed by 41.64% to 0.03 in 2022, then plummeted by 39.77% to 0.02 in 2023.
  • Its last three reported values are 0.02 in Q2 2023, 0.02 for Q1 2023, and 0.03 during Q4 2022.